Allergy Therapeutics launches biomarker study of peanut allergy vaccine candidate
Study will take place at Imperial College London
Read More
Tag: Biomarker study
- Kainova Therapeutics reports positive phase 1 results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for phase 2a trial of EBX‑102‑02 in stem cell transplant patients
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
